Groundbreaking bowel cancer trial follow-up shows zero relapses

Patients with a specific bowel cancer who were given short-course immunotherapy before surgery, instead of post-op chemotherapy, remained ca [...]

(Publication) A comparison of two manufacturing methods in the phase I COBALT study of CD19CAR T for LBCL

Claire Roddie, Juliana Dias, Gordon Weng-Kit Cheung, Maeve A. O’Reilly, Mahnaz Abbasian, Amaia Cadinanos-Garai, Ketki Vispute, Leticia Bossh [...]

(Publication) A new validated staging system for AL amyloidosis with Stage IIIC defining ultra-poor risk: AL International Staging System (AL-ISS)

Khwaja J, Kirkwood AA, Milani P, Yohannan B, Theodorakakou F, Weverling F, Di Simone V, Ravichandran S, Kumar S, Petropoulos I, Mussinelli R [...]

(Publication) New Validated Staging System for Light Chain (AL) Amyloidosis With Stage IIIC Defining Ultra-Poor Risk: AL International Staging System

Khwaja J, Kirkwood AA, Milani P, Yohannan B, Theodorakakou F, Weverling F, Di Simone V, Ravichandran S, Kumar S, Petropoulos I, Mussinelli R [...]